Organto Foods Inc. Expects Strong 2026 Growth Driven by Retail Wins and Expanded Supply Partnerships
VANCOUVER, BC AND BREDA, THE NETHERLANDS / ACCESS Newswire / February 5, 2026 / Organto
VANCOUVER, BC AND BREDA, THE NETHERLANDS / ACCESS Newswire / February 5, 2026 / Organto
NEW YORK CITY, NEW YORK / ACCESS Newswire / February 5, 2026 / Stagwell (NASDAQ:STGW),
The funding backs continued innovation in production-grade forecasting, anomaly detection, and artificial intelligence. SAN FRANCISCO,
New Research Initiative to Test if Ionization Can Remove Harmful Particles From the Atmosphere Before
ESTERO, FL / ACCESS Newswire / February 5, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP)
FAIRFIELD, NEW JERSEY / ACCESS Newswire / February 5, 2026 / Jerash Holdings (US), Inc.
Unconstrained Growth Potential: 3.3 km Drilled Mineralized Strike x 700 m Width x 300 m
SUNNY ISLES BEACH, FLORIDA / ACCESS Newswire / February 5, 2026 / Elektros Inc. (OTC
AI Nose integration positions robotics application as a scalable growth engine Mirle partnership expands SmellTech
Thermal management systems transform how buildings use heat by recovering and reusing energy that would
HOT SPRINGS, ARKANSAS / ACCESS Newswire / February 5, 2026 / Glo Tanning announces the
ABILENE, TEXAS / ACCESS Newswire / February 5, 2026 / Glo Tanning is announcing the
Strategic staking has taken place by the Company to secure key ground adjacent to modeled
TORONTO, ON / ACCESS Newswire / February 5, 2026 / Nextech3D.ai (OTCQB:NEXCF)(CSE:NTAR)(FSE:1SS), an AI-first technology
Fourth quarter revenue increased 10% year-over-year to $1,716 million Fourth quarter gross margin of 59%,
Designed by Dominican artist Willy Gómez, the aircraft will debut this spring NEW YORK–(BUSINESS WIRE)–JetBlue
London, United Kingdom–(Newsfile Corp. – February 4, 2026) – Football predictions are becoming increasingly unpredictable,
SAN FRANCISCO, Feb. 4, 2026 /PRNewswire/ — Krikey AI, a leader in generative 3D animation
– Lezhin Entertainment Targets Global Short-Form Drama Market with Original IP– Renowned Korean Directors Lee
Axon Neuroscience’s active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to